Logos Global Management LP Mereo Biopharma Group PLC Transaction History

Logos Global Management LP

  • $1.07 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.04 - $1.7 $48,863 - $79,872
-46,984 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$2.94 - $4.08 $138,132 - $191,694
46,984 New
46,984 $149,000
Q3 2020

Nov 16, 2020
SELL
$2.55 - $3.29 $509,999 - $658,000
-200,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$1.0 - $3.4 $200,000 - $680,000
200,000 New
200,000 $612,000

Others Institutions Holding MREO

# of Institutions
83
Shares Held
102M
Call Options Held
121K
Put Options Held
208K
View Full List

About Mereo Biopharma Group plc

MREO Quotes by TradingView
  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $535M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email